Sergio Quezada
Fondatore presso ACHILLES THERAPEUTICS PLC
Patrimonio netto: 288 901 $ in data 30/04/2024
Posizioni attive di Sergio Quezada
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| ACHILLES THERAPEUTICS PLC | Direttore Tecnico/Scientifico/R&S | 01/11/2020 | - |
| Fondatore | 01/11/2020 | - | |
| University College London | Corporate Officer/Principal | 01/01/2011 | - |
Storia della carriera di Sergio Quezada
Precedenti posizioni note di Sergio Quezada
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Achilles Therapeutics UK Ltd.
 Achilles Therapeutics UK Ltd. BiotechnologyHealth Technology Achilles Therapeutics Ltd. operates as a biopharmaceutical company. The firm develops personalized vaccines and adoptive T cell therapies to treat metastatic cancer. It uses DNA sequencing data from each patient, together with a proprietary bioinformatics platform, to identify clonal neoantigens specific to that patient and enable the development of personalised cell therapies. The company was founded by Karl Peggs, Mark Lowdell, Charles Swanton and Sergio Quezada in May 2016 and is headquartered in London, the United Kingdom. | Fondatore | 01/05/2016 | - |
Formazione di Sergio Quezada
| Dartmouth Medical School | Doctorate Degree |
| Pontificia Universidad Católica de Chile | Undergraduate Degree |
Statistiche
Distribuzione geografica
| Regno Unito | 4 |
| Stati Uniti | 2 |
| Cile | 2 |
Posizioni
| Founder | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
| Corporate Officer/Principal | 1 |
Settori
| Consumer Services | 4 |
| Health Technology | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
 | Health Technology |
| ACHILLES THERAPEUTICS PLC | Health Technology |
- Borsa valori
- Insiders
- Sergio Quezada
- Esperienza
